These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 1940122

  • 1. Vigabatrin in childhood epilepsy.
    Dulac O, Chiron C, Luna D, Cusmai R, Pajot N, Beaumont D, Mondragon S.
    J Child Neurol; 1991; Suppl 2():S30-7. PubMed ID: 1940122
    [Abstract] [Full Text] [Related]

  • 2. Dose-response study of vigabatrin in children with refractory epilepsy.
    Herranz JL, Arteaga R, Farr IN, Valdizan E, Beaumont D, Armijo JA.
    J Child Neurol; 1991; Suppl 2():S45-51. PubMed ID: 1940124
    [Abstract] [Full Text] [Related]

  • 3. [New drugs in the treatment of childhood epilepsy: vigabatrin (study of 61 subjects)].
    Raucci U, Spalice A, Basile LA, Guardalà C, Nasta L, Terenzi S, Iannetti P.
    Pediatr Med Chir; 1994; 16(6):575-8. PubMed ID: 7708543
    [Abstract] [Full Text] [Related]

  • 4. Vigabatrin in pediatric epilepsy--an open study.
    Uldall P, Alving J, Gram L, Beck S.
    J Child Neurol; 1991; Suppl 2():S38-44. PubMed ID: 1940123
    [Abstract] [Full Text] [Related]

  • 5. Therapeutic trial of vigabatrin in refractory infantile spasms.
    Chiron C, Dulac O, Beaumont D, Palacios L, Pajot N, Mumford J.
    J Child Neurol; 1991; Suppl 2():S52-9. PubMed ID: 1940125
    [Abstract] [Full Text] [Related]

  • 6. The role of vigabatrin in the management of infantile epileptic syndromes.
    Appleton RE.
    Neurology; 1993 Nov; 43(11 Suppl 5):S21-3. PubMed ID: 8232983
    [Abstract] [Full Text] [Related]

  • 7. Vigabatrin in refractory epilepsy in adults and its application in children.
    Dam M.
    J Child Neurol; 1991 Nov; Suppl 2():S25-9. PubMed ID: 1940120
    [Abstract] [Full Text] [Related]

  • 8. Vigabatrin in pediatric patients with refractory epilepsy.
    Turanli G, Celebi A, Yalnizoğlu D, Topçu M, Topaloğlu H, Banu A, Aysun S.
    Turk J Pediatr; 2006 Nov; 48(1):25-30. PubMed ID: 16562782
    [Abstract] [Full Text] [Related]

  • 9. [Treatment of West syndrome].
    Cvitanović-Sojat L, Gjergja R, Sabol Z, Hajnzić TF, Sojat T.
    Acta Med Croatica; 2005 Nov; 59(1):19-29. PubMed ID: 15813352
    [Abstract] [Full Text] [Related]

  • 10. The potential for increasing seizure frequency, relapse, and appearance of new seizure types with vigabatrin.
    Lortie A, Chiron C, Mumford J, Dulac O.
    Neurology; 1993 Nov; 43(11 Suppl 5):S24-7. PubMed ID: 8232984
    [Abstract] [Full Text] [Related]

  • 11. [Therapeutic options provided by new antiepileptic drugs].
    Baulac M, Arzimanoglou A, Semah F, Cavalcanti D.
    Rev Neurol (Paris); 1997 Feb; 153(1):21-33. PubMed ID: 9296153
    [Abstract] [Full Text] [Related]

  • 12. Treatment of pediatric epilepsies with gamma-vinyl GABA (vigabatrin).
    Gram L, Sabers A, Dulac O.
    Epilepsia; 1992 Feb; 33 Suppl 5():S26-9. PubMed ID: 1425497
    [Abstract] [Full Text] [Related]

  • 13. Use of antiepileptic drugs in the treatment of epilepsy in people with intellectual disability.
    Alvarez N, Besag F, Iivanainen M.
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():1-15. PubMed ID: 10030426
    [Abstract] [Full Text] [Related]

  • 14. [Treatment of refractory infantile epilepsy with vigabatrin in a series of 55 patients].
    López-Valdés E, Hernández-Laín A, Simón R, Porta J, Mateos F.
    Rev Neurol; 1996 Oct; 24(134):1255-7. PubMed ID: 8983724
    [Abstract] [Full Text] [Related]

  • 15. Gamma-vinyl GABA (vigabatrin): clinical experience in adult and adolescent patients with intractable epilepsy.
    Reynolds EH.
    Epilepsia; 1992 Oct; 33 Suppl 5():S30-4; discussion S34-5. PubMed ID: 1425498
    [Abstract] [Full Text] [Related]

  • 16. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E, Cloyd J, Critchley D, Fuseau E.
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [Abstract] [Full Text] [Related]

  • 17. Antiepileptic efficacy of vigabatrin in people with severe epilepsy and intellectual disability.
    Ylinen A.
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():46-9. PubMed ID: 10030432
    [Abstract] [Full Text] [Related]

  • 18. [Vigabatrin in childhood epilepsy--personal experience].
    Zubcević S, Gavranović M, Catibusić F, Uzicanin S, Buljina A.
    Med Arh; 1999 Dec; 53(3 Suppl 2):63-5. PubMed ID: 10758766
    [Abstract] [Full Text] [Related]

  • 19. Vigabatrin in childhood epilepsy: a 5-year follow-up study.
    Uldall P, Alving J, Gram L, Høgenhaven H.
    Neuropediatrics; 1995 Oct; 26(5):253-6. PubMed ID: 8552215
    [Abstract] [Full Text] [Related]

  • 20. Randomized controlled pilot study of vigabatrin versus carbamazepine monotherapy in newly diagnosed patients with epilepsy: an interim report.
    Kälviäinen R, Aikiä M, Partanen J, Sivenius J, Mumford J, Saksa M, Riekkinen PJ.
    J Child Neurol; 1991 Oct; Suppl 2():S60-9. PubMed ID: 1940126
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.